A novel use of attenuation value (Hounsfield unit) in non-contrast CT: diagnosis of pyonephrosis in obstructed systems.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 02 07 2019
accepted: 14 09 2019
pubmed: 22 9 2019
medline: 15 12 2020
entrez: 22 9 2019
Statut: ppublish

Résumé

To evaluate the predictive value of attenuation value (HU) in renal pelvis urine for detecting renal pelvis urine culture (RPUC) positivity in obstructed urinary systems. The study group consisted of patients who had nephrostomy insertion performed because of obstructed system and suspicion of pyonephrosis and percutaneous nephrolithotomy (PCNL) patients who had obstructed calculi. Group 1 consisted of RPUC positive 28 patients during nephrostomy insertion or needle access in PCNL and group 2 consisted of 23 patients with negative RPUC. RPUC results and non-contrast computed tomography measurements [Hounsfield unit (HU)] were compared between group 1 and group 2. A cut-off value was determined for HU. All patients were grouped according to whether they were above or below this value. The median HU calculated from the renal pelvis was - 8.5 (range - 29/- 1) and 10 (range- 4/+ 17) (p < 0.001) in group 1 and group 2, respectively. The cut-off value of HU that predicted positive RPUC was 0. Sensitivity and specificity of HU when considering this cut-off value were 100% and 96%, respectively (p < 0.001). Whereas RPUC positivity was found in 96.6% (28/29) of patients with HU < 0, there were no patients with HU > 0 where RPUC positivity was detected (p < 0.001). In this cohort, we found that HU of the urine in the renal pelvis can be used to predict RPUC positivity.

Identifiants

pubmed: 31541403
doi: 10.1007/s11255-019-02283-2
pii: 10.1007/s11255-019-02283-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-14

Références

Acad Radiol. 2012 Jul;19(7):811-8
pubmed: 22521729
Abdom Imaging. 1993;18(1):82-7
pubmed: 8431699
Can Assoc Radiol J. 2013 Feb;64(1):46-50
pubmed: 22397828
World J Urol. 2017 Mar;35(3):437-442
pubmed: 27369294
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):617-24
pubmed: 8810595
Int J Antimicrob Agents. 2011 Dec;38 Suppl:51-7
pubmed: 21993485
Int Urol Nephrol. 2018 Sep;50(9):1557-1562
pubmed: 30054864
Crit Rev Diagn Imaging. 1997 Oct;38(5):369-415
pubmed: 9391748
J Radiol. 1980 Jun-Jul;61(6-7):459-68
pubmed: 7401029
AJR Am J Roentgenol. 1999 Sep;173(3):747-55
pubmed: 10470916
Intensive Care Med. 2000;26 Suppl 1:S64-74
pubmed: 10786961
Ann Intern Med. 2013 Apr 16;158(8):588-95
pubmed: 23588747
BJU Int. 2012 Dec;110(11 Pt B):E438-42
pubmed: 22372937
Diagn Microbiol Infect Dis. 2005 Oct;53(2):143-7
pubmed: 16168611
Infect Dis Clin North Am. 1997 Sep;11(3):681-705
pubmed: 9378930
Acute Med Surg. 2016 Nov 10;4(2):184-189
pubmed: 29123859
Urol Nefrol (Mosk). 1990 Jul-Aug;(4):9-13
pubmed: 1703366
JAMA. 1997 Jul 16;278(3):234-40
pubmed: 9218672
JAMA. 1995 Jan 11;273(2):117-23
pubmed: 7799491
Am J Emerg Med. 2016 Apr;34(4):694-6
pubmed: 26905806

Auteurs

Ismail Basmaci (I)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Saim Cikrikci Str. No. 59, Bozyaka, Izmir, Turkey. ibasmaci@yahoo.com.

Ertugrul Sefik (E)

Department of Urology, HSU Izmir Bozyaka Training and Research Hospital, Saim Cikrikci Str. No. 59, Bozyaka, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH